DCGI Accuses Novartis Of Submitting False Document For Veterinary Drug
This article was originally published in PharmAsia News
Executive Summary
The Drug Controller General of India accused Novartis of submitting a fake document regarding one of its veterinary medicines, leading to cancellation of its import license.